Research Site

Otwock 05-400

1 studies enrolling now · 6 studies all time

What they study most

Advanced Clear Cell Renal Cell Carcinoma, Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer, Metastatic Clear Cell Renal Cell Carcinoma, Non-small Cell Lung Cancer, Papillary Renal Cell Carcinoma, Stage IB-IIIA Non-small Cell Lung Carcinoma, Urothelial Cancer

Studies at this site

• Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma — Recruiting now
• Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer — Running, not enrolling
• Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC — Running, not enrolling
• AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer — Completed
• AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy. — Running, not enrolling
• Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START) — Completed